Schedule 13G ownership disclosure

AMBRX BIOPHARMA INC

Security class unavailable · CUSIP: 02290A102

Event date: 2023-03-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,537,500
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-033305
Form type
SC 13G
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Mar 16, 2023
Reporting period
Mar 06, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub